1-4 of 4
Zeyad Khalaf
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Functional high-risk Relapsed/Refractory multiple myeloma (RRMM) outcomes with belantamab mafodotin (belamaf): Dreamm-7 and dreamm-8 subgroup analysis

Free
María-Victoria Mateos, Vania Hungria, Meral Beksac, Pawel Robak, Kihyun Kim, Sergei Voloshin, Hanlon Sia, Esther González García, Gracia Martinez, Chang-Ki Min, Marcelo Pitombeira de Lacerda, Anna Sureda Balarí, Ivan Špička, Sosana Delimpasi, Marek Hus, Vera Zherebtsova, Christopher Ward, Phoebe Joy Ho, Roman Hajek, Sebastian Grosicki, Syed Zafar, Al-Ola Abdallah, Jorge Mouro, Zeyad Khalaf, Hena Baig, Ainslee Moore, Chee Paul Lin, Maureen Nichols, Ianire Garrobo-Calleja, Sybil Varghese, Nick Pirooz, Joe Lee, Lydia Eccersley, Elisabet Manasanch, Ludek Pour, Meletios Dimopoulos
Journal: Blood
Blood (2025) 146 (Supplement 1): 5820.
https://doi.org/10.1182/blood-2025-5820
Published: 2025
Journal Articles

Long-term responders from the Phase 3 dreamm-7 study of belantamab mafodotin plus bortezomib and dexamethasone vs daratumumab plus bortezomib and dexamethasone in Relapsed/Refractory multiple myeloma

Free
Vania Hungria, Pawel Robak, Marek Hus, Vera Zherebtsova, Christopher Ward, Phoebe Joy Ho, Roman Hajek, Kihyun Kim, Sebastian Grosicki, Hanlon Sia, Adam Bryant, Marcelo Pitombeira de Lacerda, Gracia Martinez, Anna Sureda Balarí, Michał Mielnik, Maureen Nichols, Jorge Mouro, Zeyad Khalaf, Hena Baig, Margaret Polinkovsky, Nick Pirooz, Sybil Varghese, Joe Lee, Lydia Eccersley, María-Victoria Mateos
Journal: Blood
Blood (2025) 146 (Supplement 1): 2262.
https://doi.org/10.1182/blood-2025-2262
Published: 2025
Journal Articles

Impact of belantamab mafodotin–containing regimens on renal function in patients with Relapsed/Refractory multiple myeloma (RRMM) and mild/moderate renal impairment in the dreamm-7 and dreamm-8 trials

Free
Marcelo Pitombeira de Lacerda, Meletios Dimopoulos, Ludek Pour, Kihyun Kim, Sergei Voloshin, Hanlon Sia, Esther González García, Chang-Ki Min, Anna Sureda Balarí, Ivan Špička, Pawel Robak, Marek Hus, Vera Zherebtsova, Merit Hanna, Vinay Jadhav, Jorge Mouro, Zeyad Khalaf, Nick Pirooz, Ianire Garrobo-Calleja, Lydia Eccersley, Elisabet Manasanch, Vania Hungria, Meral Beksac
Journal: Blood
Blood (2025) 146 (Supplement 1): 2260.
https://doi.org/10.1182/blood-2025-2260
Published: 2025
Journal Articles

Patients with Relapsed/Refractory multiple myeloma who achieved sustained minimal residual disease negativity in the dreamm-7 trial

Free
María-Victoria Mateos, Pawel Robak, Marek Hus, Vera Zherebtsova, Christopher Ward, Phoebe Joy Ho, Roman Hajek, Kihyun Kim, Sebastian Grosicki, Hanlon Sia, Adam Bryant, Marcelo Pitombeira de Lacerda, Gracia Martinez, Anna Sureda Balarí, Jie Ma, Yinjiao Ma, Maureen Nichols, Jorge Mouro, Zeyad Khalaf, Hena Baig, Benga Kazeem, Nick Pirooz, Sybil Varghese, Joe Lee, Lydia Eccersley, Vania Hungria
Journal: Blood
Blood (2025) 146 (Supplement 1): 2265.
https://doi.org/10.1182/blood-2025-2265
Published: 2025